Bavarian Nordic updates on breast cancer vaccine studies

[News]

Bavarian Nordic today provided updated data from its clinical studies with its breast cancer vaccine, MVA-BN(R)-HER2, in development as therapy of metastatic breast cancer patients whose tumours over-express HER2.

More... (http://www.news-medical.net/?id=46112)